Accelerating HHV Therapeutics from Discovery to Pre-clinical
Your dedicated research partner for novel antiviral drugs, vaccines, and diagnostics targeting the entire human herpesvirus family.
Learn More
Explore Our Comprehensive Services
Our services span multiple aspects of HHV research, including virology, antiviral screening, vaccine pre-clinical evaluations, and custom research projects.
Learn More
HHV Knowledge Center
Our knowledge center offers valuable insights into herpesvirus types, associated diseases, antiviral drug development, and vaccine R&D.
Learn More
CD BioSciences
Your Strategic Partner in Human Herpesvirus Research
At CD BioSciences, we focus exclusively on the complexities of human herpesviruses. We empower pharmaceutical companies, academic institutions, and biotech innovators by providing an integrated ecosystem of specialized pre-clinical services, high-quality reagents, and expert-driven solutions. Our mission is to help you overcome the unique challenges of HHV research and accelerate the development of next-generation therapies. We are your dedicated partner, from target validation to IND-enabling studies.
Herpes Simplex Virus
Our Comprehensive HHV Portfolio
Integrated Program Solutions
Partner with us for end-to-end support. We offer integrated solutions that combine our products and services to streamline your preclinical pipeline and achieve milestones faster.
Specialized Preclinical Services
Utilize our extensive suite of services, from custom assay development and antiviral screening to in vivo model creation, all tailored to your specific HHV project needs.
High-Quality Research Products
Access a comprehensive catalog of validated reagents, including recombinant proteins, antibodies, viral particles, and stable cell lines to support your HHV research.
End-to-End Pre-clinical Solutions for HHV
Antiviral Drug Discovery
Integrated services from target identification and hit-to-lead generation to a complete pre-clinical candidate nomination package.
Vaccine Development
Accelerate your vaccine program with our support in antigen design, candidate evaluation, and pre-clinical immunogenicity and efficacy testing.
Diagnostics Development
Support for your diagnostic pipeline, including biomarker discovery, validation, and custom assay development services.
Oncolytic Virus (oHSV) Therapy
Comprehensive solutions for oHSV engineering, in vitro/in vivo activity assessment, and combination therapy evaluation.
CD BioSciences
Explore Our Comprehensive Services
At CD BioSciences, we focus exclusively on the complexities of human herpesviruses. We empower pharmaceutical companies, academic institutions, and biotech innovators by providing an integrated ecosystem of specialized pre-clinical services, high-quality reagents, and expert-driven solutions. Our mission is to help you overcome the unique challenges of HHV research and accelerate the development of next-generation therapies. We are your dedicated partner, from target validation to IND-enabling studies.
Service Highlights:
